Tellgen Corporation (300642.SZ) announced that its wholly-owned subsidiary, Shanghai Tellgen Diagnostics Technology Co., Ltd., recently obtained five medical device registration certificates issued by the Shanghai Medical Products Administration.

The approved products include: - Anti-dsDNA Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method) - Anti-C1q Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method) - Anti-M2-3E Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method) - Antiphospholipid Syndrome IgA Antibody Detection Kit (Flow Fluorescence Luminescence Method) - Anti-Nucleosome Antibody IgG Detection Kit (Flow Fluorescence Luminescence Method).